Related Experiment Video
Updated: May 20, 2025

05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.5K
Synthesis, Characterization, Bioevaluation, and Docking Studies of Spiroisatin-Based Hydrazide Conjugates
Muhammad Imran Ali1, Habiba Nazir2, David Mross3
1Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.
Chemistry & Biodiversity
|March 23, 2025
Summary
New spiroisatin-based hydrazide conjugates show promise as bioactive molecules. Compound IV-p demonstrated significant anticancer activity and favorable pharmacokinetic properties, suggesting potential therapeutic applications.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Spiroisatin derivatives are recognized for their diverse biological activities.
- Developing novel small molecules with therapeutic potential is crucial for drug discovery.
Purpose of the Study:
- To synthesize and characterize novel spiroisatin-based hydrazide conjugates.
- To evaluate the biological potential, including anticancer activity and biosimilarity, of these synthesized compounds.
- To investigate the binding interactions and pharmacokinetic properties of promising candidates.
Main Methods:
- Synthesis and structural characterization of spiroisatin-based hydrazide conjugates using spectral data and X-ray diffraction.
- Biological evaluation via cell painting assay and in vitro anticancer activity assessment against breast and colorectal cancer cell lines.
- Molecular docking analysis to predict binding affinities with target proteins (ferroportin, Aurora A kinase) and pharmacokinetic profiling.
Main Results:
- Compound IV-p exhibited significant cellular morphological changes (30.6%) and potent inhibition against MDA-MB-231 (82.37%) and HCT-116 (86.25%) cancer cell lines.
- Compounds IV-n, IV-p, and IV-m showed high biosimilarity to marketed drugs deferasirox and alisertib, respectively.
- Molecular docking revealed favorable binding scores for IV-p against ferroportin and Aurora A kinase, comparable to reference drugs.
- Pharmacokinetic studies indicated good oral bioavailability, balanced hydrophilicity, and minimal toxicity for the synthesized conjugates.
Conclusions:
- The synthesized spiroisatin-based hydrazide conjugates possess significant biological potential.
- Compound IV-p is a promising candidate for further development as a small bioactive molecule due to its anticancer activity and favorable drug-like properties.
- The study highlights the therapeutic potential of spiroisatin derivatives in cancer treatment and drug discovery.
Related Concept Videos
Stability of Conjugated Dienes
3.2K
Introduction
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
3.2K
Structure of Conjugated Dienes
4.8K
Introduction
Conjugated dienes are compounds characterized by the presence of alternating double and single bonds. In a conjugated system like 1,3-butadiene, the unhybridized 2p orbital on each carbon overlaps continuously, allowing the Ï electrons to be delocalized across the entire molecule. In contrast, this type of overlap does not occur in cumulated and isolated dienes, such as 2,3-pentadiene and 1,4-pentadiene, respectively. Instead, the Ï electrons remain localized between the...
Conjugated dienes are compounds characterized by the presence of alternating double and single bonds. In a conjugated system like 1,3-butadiene, the unhybridized 2p orbital on each carbon overlaps continuously, allowing the Ï electrons to be delocalized across the entire molecule. In contrast, this type of overlap does not occur in cumulated and isolated dienes, such as 2,3-pentadiene and 1,4-pentadiene, respectively. Instead, the Ï electrons remain localized between the...
4.8K

![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)